Developmental Programming of Drug Response: Microbiota as a Missing Dimension in Perinatal Drug Discovery
International Journal of Molecular Sciences · 22.05.2026 · 27 (11) · 4667
DOI: 10.3390/ijms27114667 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.05.2026. Verfasst von Yanan Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Pek…. Hauptthemen laut MEDLINE: Developmental Origins of Health and Disease, Drug Discovery, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key R&D Program of China, the Beijing Key Laboratory of Key Technologies for Preclinical Research and Development of In-novative Drugs in Pharmacokinetics and Pharmacodynamics, National Key R&D Program of China.
Abstract (Originalsprache)
Drug exposure during pregnancy and early life is typically considered a short-term clinical intervention rather than a determinant of long-term pharmacological outcomes. Consequently, the developmental context is largely absent from drug discovery and drug development paradigms, where efficacy, safety and target engagement are evaluated predominantly in adult, steady-state systems. This disconnect may contribute to unexplained variability in drug response and toxicity later in life. Pregnancy is accompanied by dynamic remodeling of the maternal gut microbiota and its metabolic output, generating bioactive microbial metabolites that regulate immune tone, metabolic homeostasis and the expression of drug-metabolizing enzymes and transporters. These microbial signals intersect with pharmacological interventions across gestation, shaping maternal pharmacokinetics, placental regulation and fetal drug exposure during developmentally sensitive windows. Importantly, microbiota–drug interactions initiated during pregnancy do not terminate at birth. Instead, they extend into infancy through vertical microbial transmission, breast milk-mediated metabolic signaling, and the immaturity of neonatal drug-handling systems, collectively contributing to developmental programming of drug responsiveness beyond early life. In this review, we propose a microbiota-informed framework that reframes perinatal drug exposure as a developmentally embedded signal operating across a maternal–placental–infant continuum. This perspective introduces a missing developmental dimension into drug discovery and highlights new opportunities to improve translational predictability and precision pharmacotherapy across the life course.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
- National Clinical Research Center for Women's Health and Obstetric and Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking U…
ORCID-Profile: Yan Wang
Förderung
- the National Key R&D Program of China
- the Beijing Key Laboratory of Key Technologies for Preclinical Research and Development of In-novative Drugs in Pharmacokinetics and Pharmacodynamics
- National Key R&D Program of China
- Beijing Key Laboratory of Key Technologies for Preclinical Research and Development of Innovative Drugs in Pharmacokinetics and Pharmacodynamics
Zitieren
APA
Zhang, Y., Ma, L., & Wang, Y. (2026). Developmental Programming of Drug Response: Microbiota as a Missing Dimension in Perinatal Drug Discovery. International Journal of Molecular Sciences, 27(11), 4667. https://doi.org/10.3390/ijms27114667
Vancouver
Zhang Y, Ma L, Wang Y. Developmental Programming of Drug Response: Microbiota as a Missing Dimension in Perinatal Drug Discovery. International Journal of Molecular Sciences. 2026;27(11):4667. doi:10.3390/ijms27114667
BibTeX
@article{Zhang2026,
author = {Zhang, Yanan and Ma, Liangkun and Wang, Yan},
title = {Developmental Programming of Drug Response: Microbiota as a Missing Dimension in Perinatal Drug Discovery},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {11},
pages = {4667},
doi = {10.3390/ijms27114667}
}
EUVIMED